ReviewJMA journal2026
Clinical Practice Guideline for Rehabilitation Nutrition 2026: Executive Summary of the Japanese Association of Rehabilitation Nutrition Guideline 2026-A Secondary Publication.
Review in JMA journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
24 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The Japanese Association of Rehabilitation Nutrition (JARN) published its first Japanese-language clinical practice guideline on rehabilitation nutrition in 2018, followed by an English-language 2020 update covering cerebrovascular disease, hip fracture, cancer, and acute illness. The JARN Clinical Practice Guideline 2026 (JARN GL 2026) expands the framework to 11 domains and incorporates updated evidence on malnutrition diagnosis using the Global Leadership Initiative on Malnutrition criteria, sarcopenia assessment, and interactions between nutritional therapy and rehabilitation. This secondary publication summarizes the scope, methods, and all statements. JARN GL 2026 was developed in accordance with the Minds Clinical Practice Guideline Development Manual 2020 (version 3.0). Clinical questions were formulated in Population, Intervention, Comparison, and Outcome format and classified as clinical questions (CQs) with graded recommendations, background questions (BQs) providing evidence-based context, or future research questions (FRQs) identifying topics with insufficient evidence. Recommendations were graded for strength (1 = strong; 2 = weak/conditional) and certainty of evidence (A-D). Patient and public involvement and external peer review by related academic societies were incorporated. Across 11 domains-cerebrovascular disease, proximal femur fracture, chronic obstructive pulmonary disease (COPD), cancer, dysphagia, intensive exercise therapy, enhanced nutritional care, oral management, pharmaceutical intervention, hospital-associated sarcopenia, and social determinants of health-12 CQs, five BQs, and three FRQs are presented. Enhanced nutritional care combined with rehabilitation was strongly recommended for patients with proximal femur fracture and weakly recommended for patients with acute- and convalescent-phase cerebrovascular disease, COPD, cancer, and dysphagia. Registered dietitian-led nutritional assessment and counseling and professional oral management concurrent with rehabilitation were each weakly recommended. Three topics were classified as FRQs because of insufficient evidence. JARN GL 2026 provides a systematically developed, evidence-graded framework to support patient-centered, multidisciplinary rehabilitation nutrition across care settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.